An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Adverse Effects of Vaccines: Evidence and Causality.
Committee to Review Adverse Effects of Vaccines; Institute of Medicine; Stratton K, Ford A, Rusch E, et al., editors.
Washington (DC): National Academies Press (US); 2011 Aug 25.
Top results in this bookTable of Contents
Safety of Vaccines Used for Routine Immunization in the United States: An Update [Internet].
Gidengil C, Goetz MB, Maglione M, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. (Comparative Effectiveness Review, No. 244.)
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2026 Jan-.
NEUROLOGY OF COVID–19 [Internet].
Priori A, editor.
Milano: Milano University Press; 2021 Feb.
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
Melendez-Torres GJ, Auguste P, Armoiry X, et al.
Southampton (UK): NIHR Journals Library; 2017 Sep. (Health Technology Assessment, No. 21.52.)
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Diseases of the Brain, Head and Neck, Spine 2024-2027: Diagnostic Imaging [Internet].
Hodler J, Kubik-Huch RA, Roos JE, editors.
Cham (CH): Springer; 2024.
Suspected neurological conditions: recognition and referral.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 127.)
Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions: A Review of Clinical Effectiveness [Internet].
Sutton D, Visintini S.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Mar 14.
Diseases of the Brain, Head and Neck, Spine 2020–2023: Diagnostic Imaging [Internet].
Hodler J, Kubik-Huch RA, von Schulthess GK, editors.
Cham (CH): Springer; 2020.
Immunization Safety Review: Influenza Vaccines and Neurological Complications.
Institute of Medicine (US) Immunization Safety Review Committee; Stratton K, Alamario DA, Wizemann T, et al., editors.
Washington (DC): National Academies Press (US); 2004.
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality.
Institute of Medicine (US) Vaccine Safety Committee; Stratton KR, Howe CJ, Johnston RB Jr, editors.
Washington (DC): National Academies Press (US); 1994.
Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders.
Institute of Medicine (US) Immunization Safety Review Committee; Stratton K, Almario D, McCormick MC, editors.
Washington (DC): National Academies Press (US); 2002.
The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects: Workshop Summary.
Institute of Medicine (US) Forum on Microbial Threats; Knobler SL, O'Connor S, Lemon SM, et al., editors.
Does Plasma Exchange Help Improve Physical Function in Children with Transverse Myelitis? – The CAPTURE Study [Internet].
Greenberg BM, Pardo C, Recio A, et al.
Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Feb.
Multiple Sclerosis: Current Status and Strategies for the Future.
Institute of Medicine (US) Committee on Multiple Sclerosis: Current Status and Strategies for the Future; Joy JE, Johnston RB Jr, editors.
Washington (DC): National Academies Press (US); 2001.
Long COVID: Examining Long-Term Health Effects of COVID-19 and Implications for the Social Security Administration: Proceedings of a Workshop.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Forstag EH, Denning LA, editors.
Washington (DC): National Academies Press (US); 2022 Jun 30.
Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Board on Global Health; Committee on The Evidence Base for Lyme Infection-Associated Chronic Illnesses Treatment; March A, Liao J, Kester K, editors.
Washington (DC): National Academies Press (US); 2025 Jun 26.
Vaccine Risk Monitoring and Evaluation at the Centers for Disease Control and Prevention.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee to Review the Centers for Disease Control and Prevention's COVID-19 Vaccine Safety Research and Communications; Ancona D, Kumova OK, Stratton K, et al., editors.
Washington (DC): National Academies Press (US); 2025 Oct 7.
Evidence reviews for diagnostic tests: Lyme disease: diagnosis and management: Evidence review C.
London: National Institute for Health and Care Excellence (NICE); 2018 Apr. (NICE Guideline, No. 95.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on